180 related articles for article (PubMed ID: 33955555)
1. Viral hepatitis in haemophilia: historical perspective and current management.
Isfordink CJ; van Erpecum KJ; van der Valk M; Mauser-Bunschoten EP; Makris M
Br J Haematol; 2021 Oct; 195(2):174-185. PubMed ID: 33955555
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-transmitted disease.
Lee CA
Baillieres Clin Haematol; 1996 Jun; 9(2):369-94. PubMed ID: 8800511
[TBL] [Abstract][Full Text] [Related]
3. Survival of hepatitis C-infected haemophilia patients is predicted by presence of cirrhosis but not by anti-viral treatment.
Maor Y; Schapiro JM; Bashari D; Martinowitz U
Ann Hepatol; 2014; 13(6):753-61. PubMed ID: 25332261
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment.
Posthouwer D; Plug I; van der Bom JG; Fischer K; Rosendaal FR; Mauser-Bunschoten EP
Haemophilia; 2005 May; 11(3):270-5. PubMed ID: 15876273
[TBL] [Abstract][Full Text] [Related]
5. GB virus C/hepatitis G virus infection in HIV infected patients with haemophilia despite treatment with virus inactivated clotting factor concentrates.
Woelfle J; Berg T; Bialek R; Keller KM; Effenberger W; Wagner N
Arch Dis Child; 1999 May; 80(5):429-32. PubMed ID: 10208947
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum of viral infections in hemophilic patients.
Telfer MC
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1047-56. PubMed ID: 1328142
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.
Mannucci PM
Vox Sang; 1993; 64(4):197-203. PubMed ID: 8517048
[TBL] [Abstract][Full Text] [Related]
8. [Blood-transmitted viral infections among haemophiliacs in Tunisia].
Langar H; Triki H; Gouider E; Bahri O; Djebbi A; Sadraoui A; Hafsia A; Hafsia R
Transfus Clin Biol; 2005 Oct; 12(4):301-5. PubMed ID: 16099190
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C in haemophilia: lights and shadows.
Rumi MG; De Filippi F; Santagostino E; Colombo M
Haemophilia; 2004 Oct; 10 Suppl 4():211-5. PubMed ID: 15479400
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003.
Goedert JJ;
Haemophilia; 2005 Sep; 11(5):516-28. PubMed ID: 16128897
[TBL] [Abstract][Full Text] [Related]
11. Viral pathogens.
Ragni MV; Sherman KE; Jordan JA
Haemophilia; 2010 Jul; 16 Suppl 5():40-6. PubMed ID: 20590855
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease.
Leslie DE; Rann S; Nicholson S; Fairley CK; Gust ID
Med J Aust; 1992 Jun; 156(11):789-92. PubMed ID: 1321326
[TBL] [Abstract][Full Text] [Related]
13. [Recommendations of Gesida/PNS/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus].
Panel de expertos de Gesida, Secretaría del Plan Nacional sobre el Sida (SPNS) y Asociación Española para el Estudio del Hígado (AEEH)
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):31.e1-31. PubMed ID: 20116629
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors.
Ter-Zakarian A; Barnes RFW; Kruse-Jarres R; Quon DV; Jackson S; Sun HL; von Drygalski A
Haemophilia; 2022 Nov; 28(6):977-985. PubMed ID: 35768896
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis and HIV infection during haemodialysis.
Saha D; Agarwal SK
J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
[TBL] [Abstract][Full Text] [Related]
16. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation.
Darby SC; Ewart DW; Giangrande PL; Spooner RJ; Rizza CR; Dusheiko GM; Lee CA; Ludlam CA; Preston FE
Lancet; 1997 Nov; 350(9089):1425-31. PubMed ID: 9371165
[TBL] [Abstract][Full Text] [Related]
17. Diabetes, hepatitis C and human immunodeficiency virus influence hypertension risk differently in cohorts of haemophilia patients, veterans and the general population.
Barnes RFW; Pandey B; Sun HL; Jackson S; Kruse-Jarres R; Quon DV; von Drygalski A
Haemophilia; 2022 Nov; 28(6):e228-e236. PubMed ID: 35877992
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
Meili EO
Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
[TBL] [Abstract][Full Text] [Related]
19. Blood safety monitoring among persons with bleeding disorders--United States, May 1998-June 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Jan; 51(51-52):1152-4. PubMed ID: 12553567
[TBL] [Abstract][Full Text] [Related]
20. Chronic hepatitis in haemophilia.
Makris M; Preston FE
Blood Rev; 1993 Dec; 7(4):243-50. PubMed ID: 7510563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
